These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16110761)

  • 1. Prognostic value of DNA analysis of prostate adenocarcinoma: correlation to clinicopathologic predictors.
    Bantis A; Gonidi M; Athanassiades P; Tsolos Ch; Liossi A; Aggelonidou E; Athanassiadou AM; Petrakakou E; Athanassiadou P
    J Exp Clin Cancer Res; 2005 Jun; 24(2):273-8. PubMed ID: 16110761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.
    Abaza R; Diaz LK; Laskin WB; Pins MR
    J Urol; 2006 Dec; 176(6 Pt 1):2701-5. PubMed ID: 17085199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of patients with low-risk for aneuploidy: comparative discriminatory models using linear and machine-learning classifiers in prostate cancer.
    Venkataraman G; Heinze G; Holmes EW; Ananthanarayanan V; Bostwick DG; Paner GP; Bradford-De La garza CM; Brown HG; Flanigan RC; Wojcik EM
    Prostate; 2007 Oct; 67(14):1524-36. PubMed ID: 17683063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase expression as a marker in prostate cancer: correlation to clinicopathologic predictors.
    Athanassiadou P; Bantis A; Gonidi M; Liossi A; Aggelonidou E; Petrakakou E; Giannopoulos A
    J Exp Clin Cancer Res; 2003 Dec; 22(4):613-8. PubMed ID: 15053304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of ploidy in prostatic cancer, quantified by a prospectively applicable procedure].
    Valle Gerhold J; Azua Blanco J; Villarroya Rodríguez S; Romero Casabona P
    Arch Esp Urol; 1996 Mar; 49(2):139-45. PubMed ID: 8702324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does any correlation exist between the Gleason classification system and the computer-assisted microscope analysis of Feulgen-stained nuclei features in human prostate adenocarcinoma?
    Petein M; Decaestecker C; Segers V; Janssen T; Fourmarier M; Van Leer P; van Velthoven R; Schulman C; Pasteels JL; Kiss R
    Anal Cell Pathol; 1996 Dec; 12(3):159-71. PubMed ID: 9025992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy.
    Sengupta S; Cheville JC; Lohse CM; Zincke H; Myers RP; Riehle DL; Pankratz VS; Blute ML; Sebo TJ
    Urology; 2006 Jul; 68(1):94-8. PubMed ID: 16844452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of protein expression, Gleason score and DNA ploidy in prostate cancer.
    Lexander H; Palmberg C; Hellman U; Auer G; Hellström M; Franzén B; Jörnvall H; Egevad L
    Proteomics; 2006 Aug; 6(15):4370-80. PubMed ID: 16888723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients.
    Henrique R; Ribeiro FR; Fonseca D; Hoque MO; Carvalho AL; Costa VL; Pinto M; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
    Clin Cancer Res; 2007 Oct; 13(20):6122-9. PubMed ID: 17947477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between DNA ploidy and functional estrogen receptors in operable prostate cancer.
    Nativ O; Umehara T; Colvard DS; Therneau TM; Farrow GM; Spelsberg TC; Lieber MM
    Eur Urol; 1997; 32(1):96-9. PubMed ID: 9266239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopy.
    Rickes S; Hauptmann S; Flath B; Abbenseth R; Zwiebel FM; Possinger K
    Onkologie; 2003 Feb; 26(1):32-7. PubMed ID: 12624515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma.
    Lin JK; Chang SC; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2003; 50(54):1927-32. PubMed ID: 14696434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer: indicators of aggressiveness.
    Sakr WA; Grignon DJ
    Eur Urol; 1997; 32 Suppl 3():15-23. PubMed ID: 9267782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric determination of ploidy in prostatic adenocarcinoma and its relation to clinical outcome.
    Blatstein LM; Ginsberg PC; Daskal I; Finkelstein LH
    J Am Osteopath Assoc; 1993 Apr; 93(4):463-8, 471-2. PubMed ID: 8478220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Digital image analysis in pathology--exemplified in prostatic cancer].
    Danielsen HE; Kildal W; Sudbø J
    Tidsskr Nor Laegeforen; 2000 Feb; 120(4):479-88. PubMed ID: 10833941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
    Hattab EM; Koch MO; Eble JN; Lin H; Cheng L
    J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas.
    Sheehan GM; Kallakury BV; Sheehan CE; Fisher HA; Kaufman RP; Ross JS
    Hum Pathol; 2005 Nov; 36(11):1204-9. PubMed ID: 16260274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival.
    Tollefson MK; Leibovich BC; Slezak JM; Zincke H; Blute ML
    J Urol; 2006 Feb; 175(2):547-51. PubMed ID: 16406993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear/Nucleolar morphometry and DNA image cytometry as a combined diagnostic tool in pathology of prostatic carcinoma.
    Kavantzas N; Agapitos E; Lazaris AC; Pavlopoulos PM; Sofikitis N; Davaris P
    J Exp Clin Cancer Res; 2001 Dec; 20(4):537-42. PubMed ID: 11876548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.